| 注册
首页|期刊导航|四川中医|降香清血丸治疗高原高脂血症患者的随机对照临床研究

降香清血丸治疗高原高脂血症患者的随机对照临床研究

詹昱莱 余志英 汤诺 刘珂珂 陈湋錡 邓兵 廖振中

四川中医2026,Vol.44Issue(1):76-83,8.
四川中医2026,Vol.44Issue(1):76-83,8.DOI:10.26946/j.cnki.1000-3649.sczy.2507290011

降香清血丸治疗高原高脂血症患者的随机对照临床研究

A randomized controlled clinical study on the treatment of high-altitude hyperlipidemia patients with Jiangxiang Qingxue Wan

詹昱莱 1余志英 2汤诺 3刘珂珂 3陈湋錡 3邓兵 3廖振中2

作者信息

  • 1. 上海中医药大学附属龙华医院心病科,上海 200032||同济大学附属杨浦医院中医科,上海 200082
  • 2. 迪庆藏族自治州藏医院,云南 迪庆藏族自治州 674499
  • 3. 上海中医药大学附属龙华医院心病科,上海 200032
  • 折叠

摘要

Abstract

Objective To evaluate the efficacy of Tibetan medicine Jiangxiang Qingxue Wan(JXQXW)in treating patients with high-altitude hyperlipidemia.Methods Sixty hyperlipidemia patients admitted to Diqing Tibetan Hospital from December 2020 to December 2022 were enrolled and randomly assigned to a treatment group(31 cases)or a control group(29 cases).The treatment group received JXQXW,while the control group received rosuvastatin.Total cholesterol(TC),triglycerides(TG),high density lipoprotein cholesterol(HDL-C),low-density lipoprotein cholesterol(LDL-C),Traditional Chinese Medicine(TCM)syndrome scores,and overall therapeutic efficacy were compared after 4 weeks of intervention.Results After treatment,the levels of TG,TC,and LDL-C in the treatment group significantly decreased compared to before treatment(P<0.05),while the change in HDL-C levels showed no statistical significance(P>0.05).Compared to the control group,the treatment group exhibited a more significant reduction in TG(P<0.05),but no statistical difference in the effect on HDL-C(P>0.05).The overall efficacy rate of lipid control in the treatment group was 80.65%,while that in the control group was 89.66%,with no statistically significant difference between the groups(P>0.05).In terms of improving TCM syndrome patterns,the treatment group's total efficacy rate was 93.54%,significantly higher than the control group's 62.07%(P<0.05).The treatment group demonstrated superior efficacy in alleviating symptoms such as limb heaviness,dizziness,vomiting with phlegm,and fatigue compared to the control group(P<0.05).Conclusion JXQXW effectively reduces TG,TC,and LDL-C levels in high-altitude hyperlipidemia patients,addressing the limitation of statins in TG modulation.It also significantly improves TCM syndromes and enhances quality of life,demonstrating substantial clinical value for broader application.

关键词

高原/高脂血症/藏药降香清血丸/临床研究/甘油三酯

Key words

High-altitude/Hyperlipidemia/Tibetan medicine Jiangxiang Qingxue Wan/Clinical study/Triglycerides

分类

医药卫生

引用本文复制引用

詹昱莱,余志英,汤诺,刘珂珂,陈湋錡,邓兵,廖振中..降香清血丸治疗高原高脂血症患者的随机对照临床研究[J].四川中医,2026,44(1):76-83,8.

基金项目

上海市卫生计划委员会中医适宜技术推广项目(ZY-SYJS-1). (ZY-SYJS-1)

四川中医

1000-3649

访问量1
|
下载量0
段落导航相关论文